HUE055891T2 - A gonadotropint felszabadító hormon (GNRH) receptor antagonista kristályos formája és annak elõállítási módja - Google Patents
A gonadotropint felszabadító hormon (GNRH) receptor antagonista kristályos formája és annak elõállítási módjaInfo
- Publication number
- HUE055891T2 HUE055891T2 HUE17869463A HUE17869463A HUE055891T2 HU E055891 T2 HUE055891 T2 HU E055891T2 HU E17869463 A HUE17869463 A HU E17869463A HU E17869463 A HUE17869463 A HU E17869463A HU E055891 T2 HUE055891 T2 HU E055891T2
- Authority
- HU
- Hungary
- Prior art keywords
- preparation
- crystalline form
- receptor antagonist
- method therefor
- gnrh receptor
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D473/00—Heterocyclic compounds containing purine ring systems
- C07D473/26—Heterocyclic compounds containing purine ring systems with an oxygen, sulphur, or nitrogen atom directly attached in position 2 or 6, but not in both
- C07D473/28—Oxygen atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
- C07B2200/00—Indexing scheme relating to specific properties of organic compounds
- C07B2200/13—Crystalline forms, e.g. polymorphs
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Endocrinology (AREA)
- Reproductive Health (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201610999743 | 2016-11-14 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| HUE055891T2 true HUE055891T2 (hu) | 2022-01-28 |
Family
ID=62109467
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| HUE17869463A HUE055891T2 (hu) | 2016-11-14 | 2017-11-13 | A gonadotropint felszabadító hormon (GNRH) receptor antagonista kristályos formája és annak elõállítási módja |
Country Status (16)
| Country | Link |
|---|---|
| US (1) | US10787451B2 (hu) |
| EP (1) | EP3539545B1 (hu) |
| JP (1) | JP2019535712A (hu) |
| KR (1) | KR102516017B1 (hu) |
| CN (1) | CN108778282B (hu) |
| AU (1) | AU2017357332B2 (hu) |
| BR (1) | BR112019009455A2 (hu) |
| CA (1) | CA3040026A1 (hu) |
| DK (1) | DK3539545T3 (hu) |
| ES (1) | ES2887018T3 (hu) |
| HR (1) | HRP20211379T1 (hu) |
| HU (1) | HUE055891T2 (hu) |
| PL (1) | PL3539545T3 (hu) |
| PT (1) | PT3539545T (hu) |
| TW (1) | TWI774704B (hu) |
| WO (1) | WO2018086608A1 (hu) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| SG11202111907UA (en) * | 2019-04-30 | 2021-11-29 | Beijing Tide Pharmaceutical Co Ltd | Solid form of diaminopyrimidine compound or hydrate thereof, preparation method therefor, and application thereof |
| CN117203209A (zh) * | 2021-04-02 | 2023-12-08 | 江苏恒瑞医药股份有限公司 | 一种GnRH受体拮抗剂的结晶形式及其制备方法 |
| CN117769424A (zh) * | 2021-08-30 | 2024-03-26 | 江苏恒瑞医药股份有限公司 | 一种GnRH受体拮抗剂的结晶工艺 |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2008533025A (ja) | 2005-03-07 | 2008-08-21 | ワイス | キノキサリンジヒドロハライド二水和物およびそのための合成方法 |
| JPWO2010026993A1 (ja) | 2008-09-03 | 2012-02-02 | 武田薬品工業株式会社 | 製剤における吸収性改善方法および吸収性が改善された製剤 |
| TW201130854A (en) | 2009-12-22 | 2011-09-16 | Bayer Schering Pharma Ag | Pyridinone derivatives and pharmaceutical compositions thereof |
| WO2012175514A1 (en) | 2011-06-21 | 2012-12-27 | Bayer Intellectual Property Gmbh | Pyridinone derivatives and pharmaceutical compositions thereof |
| UY35058A (es) * | 2012-09-28 | 2014-04-30 | Takeda Pharmaceutical | Método de producción de derivado de tienopirimidina |
| SI3064498T1 (sl) * | 2013-10-30 | 2019-11-29 | Shanghai hengrui pharmaceutical co ltd | Derivati pirazolopirimidona ali pirolotriazona, postopki priprave le-teh in farmacevtske uporabe le-teh |
| CN104788435A (zh) * | 2014-01-16 | 2015-07-22 | 江苏恒瑞医药股份有限公司 | 一种蛋白酪氨酸激酶抑制剂的二苯磺酸盐的i型结晶 |
-
2017
- 2017-11-13 WO PCT/CN2017/110685 patent/WO2018086608A1/zh active Application Filing
- 2017-11-13 JP JP2019525785A patent/JP2019535712A/ja active Pending
- 2017-11-13 ES ES17869463T patent/ES2887018T3/es active Active
- 2017-11-13 BR BR112019009455A patent/BR112019009455A2/pt active Search and Examination
- 2017-11-13 CA CA3040026A patent/CA3040026A1/en active Pending
- 2017-11-13 KR KR1020197015658A patent/KR102516017B1/ko active IP Right Grant
- 2017-11-13 TW TW106139177A patent/TWI774704B/zh not_active IP Right Cessation
- 2017-11-13 PL PL17869463T patent/PL3539545T3/pl unknown
- 2017-11-13 CN CN201780017902.8A patent/CN108778282B/zh active Active
- 2017-11-13 AU AU2017357332A patent/AU2017357332B2/en not_active Ceased
- 2017-11-13 PT PT178694634T patent/PT3539545T/pt unknown
- 2017-11-13 HU HUE17869463A patent/HUE055891T2/hu unknown
- 2017-11-13 DK DK17869463.4T patent/DK3539545T3/da active
- 2017-11-13 EP EP17869463.4A patent/EP3539545B1/en active Active
- 2017-11-13 US US16/348,932 patent/US10787451B2/en active Active
-
2021
- 2021-08-30 HR HRP20211379TT patent/HRP20211379T1/hr unknown
Also Published As
| Publication number | Publication date |
|---|---|
| KR20190080915A (ko) | 2019-07-08 |
| JP2019535712A (ja) | 2019-12-12 |
| CN108778282B (zh) | 2021-07-27 |
| BR112019009455A2 (pt) | 2019-07-30 |
| AU2017357332A1 (en) | 2019-05-09 |
| KR102516017B1 (ko) | 2023-03-30 |
| PT3539545T (pt) | 2021-09-06 |
| US20190276455A1 (en) | 2019-09-12 |
| ES2887018T3 (es) | 2021-12-21 |
| TW201817734A (zh) | 2018-05-16 |
| TWI774704B (zh) | 2022-08-21 |
| AU2017357332B2 (en) | 2021-10-28 |
| CA3040026A1 (en) | 2018-05-17 |
| WO2018086608A1 (zh) | 2018-05-17 |
| US10787451B2 (en) | 2020-09-29 |
| EP3539545A4 (en) | 2020-07-01 |
| EP3539545A1 (en) | 2019-09-18 |
| HRP20211379T1 (hr) | 2021-12-10 |
| PL3539545T3 (pl) | 2022-01-10 |
| CN108778282A (zh) | 2018-11-09 |
| EP3539545B1 (en) | 2021-08-11 |
| DK3539545T3 (da) | 2021-09-27 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| HK1250710A1 (zh) | 用於製備雄激素受體拮抗劑及其中間體的方法 | |
| IL253360A0 (en) | New crystalline forms of neratinib malate and a process for their preparation | |
| IL284005A (en) | Glucocorticoid receptor inhibitors | |
| LT3495352T (lt) | Androgeno receptoriaus antagonisto kristalinės formos, paruošimo būdas ir jų panaudojimas | |
| PT3411378T (pt) | Formas cristalinas de monofumarato de tenofovir alafenamida | |
| LT3327012T (lt) | Bilastino kristalinės formos ir jų gamybos būdai | |
| PT3539545T (pt) | Forma cristalina de antagonista do recetor de gnrh e método para a preparação da mesma | |
| EP3313396A4 (en) | G-PROTEIN-COUPLED RECEPTOR CINASE INHIBITORS AND METHOD OF USE THEREOF | |
| HK1250163A1 (zh) | 作為5-氧代-ete受體拮抗劑的吲哚類似物及其使用方法 | |
| EP3134092A4 (en) | Pharmaceutical salts of an orexin receptor antagonist | |
| HK1247105A1 (zh) | Mu類鴉片受體拮抗劑與類鴉片藥劑的組合劑型 | |
| HUE050459T2 (hu) | Androgénreceptor-gátló kristályformája és annak elõállítási eljárása | |
| EP3336088A4 (en) | CRYSTALLINE FORM OF THE OREXIN RECEPTOR ANTAGONIST COMPOUND, PREPARATION METHOD AND APPLICATION THEREOF | |
| EP3674294C0 (en) | N-FORMYL VORTIOXETINE, METHOD FOR PREPARING IT AND SOLID PREPARATION OF VORTIOXETINE | |
| TH1501006213A (th) | รูปแบบยาของโพรเจสเทอโรนรีเซปเตอร์แอนตะกอนิสต์ |